Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Geloprep is a gel-based bowel preparation agent developed by Zealand University Hospital for colonic cleansing prior to colonoscopy or CT colonography. Formulated as an alternative to traditional large-volume liquid osmotic laxatives (such as Moviprep), Geloprep aims to improve patient adherence and tolerability by providing the cleansing agent in a gel format. It functions as an osmotic laxative, drawing water into the intestinal lumen to soften stool and induce bowel movements, thereby ensuring a clear colon for diagnostic visualization. The intervention is identified in clinical trials by the code 'A 06 ad', which corresponds to the ATC category for osmotically acting laxatives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Geloprep.